Edwards Lifesciences (EW) is scheduled to report Q2 earnings on July 23, 2026. Analysts estimate EPS of $0.74 and quarterly revenue of $1.70B.
In the most recent quarter (Q1), Edwards Lifesciences reported EPS of $0.78, beating estimates of $0.73 by 0.07%. Revenue came in at $1.65B, exceeding the estimate of $1.59B by 0.03%.
Over the last 4 quarters, Edwards Lifesciences has averaged an EPS surprise of 0.09% and a revenue surprise of 0.03%.
Analyze the earnings history of Edwards Lifesciences using advanced sorting and filters.
The chart below shows Edwards Lifesciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Edwards Lifesciences's reported revenue compared to analyst estimates over recent quarters.
Edwards Lifesciences (EW) is scheduled to report earnings on July 23, 2026. The last reported earnings were for reported on April 23, 2026 for Q1.
The Actual EPS was $0.78, which beat the estimate of $0.73.
The Actual Revenue was $1.65B, which beat the estimate of $1.59B.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-23 | $0.78 | $0.73 | 6.85 % |
| Q4 | 2026-02-10 | $0.58 | $0.62 | -6.45 % |
| Q3 | 2025-10-30 | $0.67 | $0.59 | 13.6 % |
| Q2 | 2025-07-24 | $0.67 | $0.62 | 8.06 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-23 | $1.65B | $1.59B | 3.41 % |
| Q4 | 2026-02-10 | $1.57B | $1.54B | 1.81 % |
| Q3 | 2025-10-30 | $1.55B | $1.50B | 3.66 % |
| Q2 | 2025-07-24 | $1.53B | $1.49B | 3.01 % |